1988
DOI: 10.1111/j.1600-079x.1988.tb00788.x
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Protein Restriction, Melatonin Administration, and Short Daylength on Brain Benzodiazepine Receptors in Prepubertal Male Rats

Abstract: The possibility that there are changes in brain benzodiazepine binding sites controlled by photoperiod was investigated in two strains of male rats. The hypothesis was tested by 3H-diazepam binding studies in various brain regions of prepubertal rats maintained in 14 or 10 h of light or treated with late-afternoon injections of melatonin (50 micrograms/day). Protein restriction was applied during the experiment to sensitise the animals to the treatments. Under the conditions employed, rats kept in short daylen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

1988
1988
2009
2009

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(5 citation statements)
references
References 30 publications
0
5
0
Order By: Relevance
“…Although the exact mechanisms underlying the anticonvulsant effect of melatonin in the KA-induced limbic seizure model are not understood, melatonin is believed to influence inhibitory GABAergic neurotransmission (Golombek et al, 1996). Indeed, such an action of melatonin might interfere with KA-induced excitotoxicity and reduce toxic oxidative damage through a mechanism that does not require reactive oxygen species scavenging (Kennaway et al, 1988). Since drugs which are known to enhance GABA-mediated neurotransmission, such as diazepam, pentobarbital, and valproic acid, block both seizure activity and increases in the AP-1 binding factor (Sonnenberg et al, 1989a,b;Pennypacker et al, 1993), the anticonvulsant effect of melatonin may reduce the activation of KA-induced c-Fos, Fra-2, c-Jun, and JunB expression as well as their DNA binding activity to the AP-1 DNA motif.…”
Section: Discussionmentioning
confidence: 99%
“…Although the exact mechanisms underlying the anticonvulsant effect of melatonin in the KA-induced limbic seizure model are not understood, melatonin is believed to influence inhibitory GABAergic neurotransmission (Golombek et al, 1996). Indeed, such an action of melatonin might interfere with KA-induced excitotoxicity and reduce toxic oxidative damage through a mechanism that does not require reactive oxygen species scavenging (Kennaway et al, 1988). Since drugs which are known to enhance GABA-mediated neurotransmission, such as diazepam, pentobarbital, and valproic acid, block both seizure activity and increases in the AP-1 binding factor (Sonnenberg et al, 1989a,b;Pennypacker et al, 1993), the anticonvulsant effect of melatonin may reduce the activation of KA-induced c-Fos, Fra-2, c-Jun, and JunB expression as well as their DNA binding activity to the AP-1 DNA motif.…”
Section: Discussionmentioning
confidence: 99%
“…After the discovery of AFMK and AMK, a number of studies has analyzed the effects of these compounds, mainly but not exclusively with the intention of identifying actions related to the parent compound, melatonin. Binding of AFMK to melatonin receptors [155, 156] and to the benzodiazepine‐binding sites of GABA receptor complexes [157, 158] revealed, however, only moderate affinities. AMK binding to melatonin receptors was also almost two orders of magnitude lower than that of melatonin [159, 160]; such an action had been speculated because of potent inhibition of retinal dopamine release (reported IC 50 = 1 n m ) [130].…”
Section: Biological and Pharmacological Actionsmentioning
confidence: 99%
“…Attempts of identifying actions of AFMK were of limited success, when effects on the reproductive system [224,225] and affinities to benzodiazepine [226,227] and melatonin receptors [228,229] were investigated. However, an interesting chronobiological effect of AFMK was described, which was never followed up later in other systems, namely, an acceleration of the reentrainment of the melatonin rhythm in rats [230].…”
Section: Diversity Of Metabolism and Actions Of Metabolitesmentioning
confidence: 99%